Share 'BioMarin Update on Duchenne Muscular Dystrophy program (March 2015)'
United Parent Projects Muscular Dystrophy (UPPMD) requested an update from Biomarin seeking answers to specific questions around next steps in terms of re-dosing, NDA submission for drisapersen in the US, the development program for additional exons, and natural history study. Read the update here.
You can share this blog post in two ways…
Share this link:
Send it with your computer's email program: Email this